Bliss GVS Pharma unit clears inspection

PTI New Delhi | Updated on October 08, 2019

Drug firm Bliss GVS Pharma has said its subsidiary Kremoint Pharma has cleared an inspection of its Ambernath facility in Maharashtra by the US health regulator. The inspection by the United States Food and Drug Administration (USFDA) was conducted from June 17-20, Bliss GVS Pharma said in a statement.

“The successful audit outcome from USFDA is a reflection of the steady progress that we are making into the mature pharma markets,” Bliss GVS Pharma VP-Strategy & Business Development Gagan Harsh Sharma said.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on October 08, 2019
This article is closed for comments.
Please Email the Editor